Condition
Mesothelioma
Estimated Enrollment: 0
Age Group: 18 Years to 90 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 18M-07-2
Study First Received: April 25, 2008
Last Updated: May 19, 2014
Estimated Primary Completion Date: April 2011
Primary Outcome Measures:
The primary endpoint of the phase II trial will be time to progression|Secondary endpoints are objective response rate and overall survival
Sponsors and Collaborators:
University of Southern California|Sponsor Name Pending
Website Link: https://ClinicalTrials.gov/show/NCT00668499
